A detailed history of Focus Financial Network, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Focus Financial Network, Inc. holds 5,295 shares of AZN stock, worth $342,533. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,295
Previous 4,854 9.09%
Holding current value
$342,533
Previous $387 Million 6.55%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$76.67 - $87.62 $33,811 - $38,640
441 Added 9.09%
5,295 $413 Million
Q2 2024

Jul 22, 2024

BUY
$66.81 - $80.83 $1,870 - $2,263
28 Added 0.58%
4,854 $387 Million
Q1 2024

Apr 24, 2024

BUY
$61.03 - $69.57 $294,530 - $335,744
4,826 New
4,826 $330 Million
Q3 2023

Jul 22, 2024

SELL
$64.85 - $71.7 $28,339 - $31,332
-437 Reduced 8.23%
4,873 $330 Million
Q1 2023

Jul 22, 2024

BUY
$63.15 - $71.6 $28,796 - $32,649
456 Added 9.39%
5,310 $369 Million
Q4 2022

Jul 24, 2024

SELL
$54.21 - $70.44 $14,203 - $18,455
-262 Reduced 5.4%
4,592 $311 Million
Q3 2022

Jul 24, 2024

SELL
$53.02 - $135.75 $18,663 - $47,784
-352 Reduced 6.92%
4,733 $260 Million
Q1 2022

Jul 24, 2024

SELL
$55.72 - $67.12 $240,041 - $289,152
-4,308 Reduced 45.86%
5,085 $337 Million
Q4 2021

Jul 24, 2024

SELL
$54.02 - $63.83 $176,591 - $208,660
-3,269 Reduced 25.82%
9,393 $547 Million
Q3 2021

Jul 24, 2024

BUY
$55.56 - $60.79 $88,451 - $96,777
1,592 Added 14.38%
12,662 $760 Million
Q2 2021

Jul 24, 2024

BUY
$48.42 - $60.18 $42,222 - $52,476
872 Added 8.55%
11,070 $663 Million
Q1 2021

Jul 24, 2024

BUY
$47.16 - $54.44 $252,023 - $290,927
5,344 Added 110.09%
10,198 $507 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Focus Financial Network, Inc. Portfolio

Follow Focus Financial Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network, Inc. with notifications on news.